Abstract
Amyotrophic lateral sclerosis (ALS) is a progressive motor neurodegeneration resulting in paralysis and death from respiratory failure within 3-5 years. About 20% of familial cases are associated with mutations in the gene for copper/zinc superoxide dismutase (SOD1), which catalyses the dismutation of the superoxide radical to hydrogen peroxide and oxygen. Experimental evidence suggests mutations act by a toxic gain of function but the mechanism is unknown. There are > 60 known SOD1 mutations associated with ALS and all are dominant except for one in exon 4, a D90A substitution which is recessive. D90A pedigrees with dominant inheritance have now been reported and this apparent contradiction needs to be explained. We performed a worldwide haplotype study on 28 D90A pedigrees using six highly polymorphic microsatellite markers. We now show that all 20 recessive families share the same founder (a = 0.999), regardless of geographical location, whereas several founders exist for the eight dominant families (a = 0.385). This finding confirms that D90A can act in a dominant fashion in keeping with all other SOD1 mutations, but that on one occasion, a new instance of this mutation has been recessive. We propose a tightly linked protective factor which modifies the toxic effect of mutant SOD1 in recessive families.
Original language | English (US) |
---|---|
Pages (from-to) | 2045-2050 |
Number of pages | 6 |
Journal | Human molecular genetics |
Volume | 7 |
Issue number | 13 |
DOIs | |
State | Published - Dec 1998 |
Funding
We are grateful to all patients and relatives who contributed samples to this study. We thank Karen Morrisson and Mandy Jackson who identified the D90A mutation in the UK samples. We thank Aleks Radunovic and all clinicians who contributed samples to the study. This work was supported by grants from the Medical Research Council (UK) and the Motor Neurone Disease Association of Great Britain to the King’s Motor Neurone Disease Care and Research Centre, by the Council of Väster-botten, Sweden, the Swedish Natural Sciences Research Council, l’Association Française pour la Recherche sur la Sclerose Latérale Amyotophique, l’Association Française contre les Myopathies, the Amyotrophic Lateral Sclerosis Association and the Australian National Health and Research Council Project Grant 970104. At the time of this work A.A.C. was a Medical Research Council Clinical Training Fellow.
ASJC Scopus subject areas
- Genetics(clinical)
- Genetics
- Molecular Biology